International Journal of Epidemiology 2003;32:1-22
© International Epidemiological Association 2003
30TH THOMAS FRANCIS JR MEMORIAL LECTURE |
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
University of Bristol, Department of Social Medicine, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK.
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures.
Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization.
| Box 1 Nature announces a genetic epidemiology initiative alongside a cartoon illustrating the demise of classical epidemiology. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project ... We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission.
|
| Box 2 A taxonomy of genetic studies of public health relevance Surveillance
Aetiology
Health services research
Adapted from Khoury MJ, Burke W, Thomson EJ (eds). Genetics and Public Health in the 21st Century. Oxford: Oxford University Press, 2000.
|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Kuper, A. Nicholson, M. Kivimaki, A. Aitsi-Selmi, G. Cavalleri, J. E Deanfield, P. Heuschmann, X. Jouven, S. Malyutina, B. M Mayosi, et al. Evaluating the causal relevance of diverse risk markers: horizontal systematic review BMJ, November 5, 2009; 339(nov05_1): b4265 - b4265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Trompet, J. W. Jukema, M. B. Katan, G. J. Blauw, N. Sattar, B. Buckley, M. Caslake, I. Ford, J. Shepherd, R. G. J. Westendorp, et al. Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study Am. J. Epidemiol., November 4, 2009; (2009) kwp294v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Thomas, S. Rafiq, T. M. Frayling, S. Ebrahim, M. Kumari, J. Gallacher, L. Ferrucci, S. Bandinelli, R. B. Wallace, D. Melzer, et al. Interleukin-18 Polymorphism and Physical Functioning in Older People: A Replication Study and Meta-Analysis J Gerontol A Biol Sci Med Sci, November 1, 2009; 64A(11): 1177 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bochud, F. Marquant, P.-M. Marques-Vidal, P. Vollenweider, J. S. Beckmann, V. Mooser, F. Paccaud, and V. Rousson Association between C-Reactive Protein and Adiposity in Women J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3969 - 3977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E Rice, S. Bandinelli, A. M. Corsi, L. Ferrucci, J. M Guralnik, M. A Miller, M. Kumari, A. Murray, T. M Frayling, and D. Melzer The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies Int. J. Epidemiol., October 1, 2009; 38(5): 1374 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Davey Smith Smoking and lung cancer: causality, Cornfield and an early observational meta-analysis Int. J. Epidemiol., October 1, 2009; 38(5): 1169 - 1171. [Full Text] [PDF]
|
|
|
|
|
|
P. Brennan, J. McKay, L. Moore, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype Int. J. Epidemiol., August 1, 2009; 38(4): 971 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Frayling Commentary: A new dawn for genetic epidemiology? Int. J. Epidemiol., August 1, 2009; 38(4): 975 - 977. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, H. Li, R. J. F. Loos, Q. Qi, F. B. Hu, Y. Liu, and X. Lin RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans J. Lipid Res., July 1, 2009; 50(7): 1479 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B. G. Nordestgaard Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction JAMA, June 10, 2009; 301(22): 2331 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Lim, E-S. Tai, T. Aung, W. T. Tay, S. M. Saw, M. Seielstad, and T. Y. Wong Relation of Age-related Cataract With Obesity and Obesity Genes in an Asian Population Am. J. Epidemiol., May 15, 2009; 169(10): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Johansson, J. D. McKay, F. Wiklund, S. Rinaldi, G. Hallmans, K. Balter, H.-O. Adami, H. Gronberg, P. Stattin, and R. Kaaks Genetic Variation in the SST Gene and its Receptors in Relation to Circulating Levels of Insulin-Like Growth Factor-I, IGFBP3, and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1644 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Cain, S. R. Cole, S. Greenland, T. T. Brown, J. S. Chmiel, L. Kingsley, and R. Detels Effect of Highly Active Antiretroviral Therapy on Incident AIDS Using Calendar Period as an Instrumental Variable Am. J. Epidemiol., May 1, 2009; 169(9): 1124 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sonestedt, M. I. L. Ivarsson, S. Harlid, U. Ericson, B. Gullberg, J. Carlson, H. Olsson, H. Adlercreutz, and E. Wirfalt The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor {alpha} and {beta} Genes J. Nutr., May 1, 2009; 139(5): 993 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Founti, F Topouzis, L van Koolwijk, C E Traverso, N Pfeiffer, and A C Viswanathan Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project Br J Ophthalmol, May 1, 2009; 93(5): 577 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Wright, U. Peters, M. J. Gunter, S. C. Moore, K. A. Lawson, M. Yeager, S. J. Weinstein, K. Snyder, J. Virtamo, and D. Albanes Association of Variants in Two Vitamin E Transport Genes with Circulating Vitamin E Concentrations and Prostate Cancer Risk Cancer Res., February 15, 2009; 69(4): 1429 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rodriguez, T. R. Gaunt, and I. N. M. Day Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies Am. J. Epidemiol., February 15, 2009; 169(4): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Foley, J. M. Craig, R. Morley, C. J. Olsson, T. Dwyer, K. Smith, and R. Saffery Prospects for Epigenetic Epidemiology Am. J. Epidemiol., February 15, 2009; 169(4): 389 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rutter Epidemiological methods to tackle causal questions Int. J. Epidemiol., February 1, 2009; 38(1): 3 - 6. [Full Text] [PDF]
|
|
|
|
|
|
P. R Burton, A. L Hansell, I. Fortier, T. A Manolio, M. J Khoury, J. Little, and P. Elliott Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology Int. J. Epidemiol., February 1, 2009; 38(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shen and J. M. Ordovas Impact of Genetic and Environmental Factors on hsCRP Concentrations and Response to Therapeutic Agents Clin. Chem., February 1, 2009; 55(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clin. Chem., February 1, 2009; 55(2): 239 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schatzkin, C. C. Abnet, A. J. Cross, M. Gunter, R. Pfeiffer, M. Gail, U. Lim, and G. Davey-Smith Mendelian Randomization: How It Can--and Cannot--Help Confirm Causal Relations between Nutrition and Cancer Cancer Prevention Research, February 1, 2009; 2(2): 104 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Schumacher, J. Cockcroft, N. J. Timpson, C. M. McEniery, J. Gallacher, A. Rumley, G. Lowe, G. D. Smith, I. B. Wilkinson, and Y. Ben-Shlomo Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity Hypertension, February 1, 2009; 53(2): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Khoury and S. Wacholder Invited Commentary: From Genome-Wide Association Studies to Gene-Environment-Wide Interaction Studies--Challenges and Opportunities Am. J. Epidemiol., January 15, 2009; 169(2): 227 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Grammer, W. Marz, W. Renner, B. O. Bohm, and M. M. Hoffmann C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study Eur. Heart J., January 2, 2009; 30(2): 170 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Boccia, M. Hashibe, P. Galli, E. De Feo, T. Asakage, T. Hashimoto, A. Hiraki, T. Katoh, T. Nomura, A. Yokoyama, et al. Aldehyde Dehydrogenase 2 and Head and Neck Cancer: A Meta-analysis Implementing a Mendelian Randomization Approach Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 248 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamaji, M. Iwasaki, S. Sasazuki, H. Sakamoto, T. Yoshida, and S. Tsugane Methionine Synthase A2756G Polymorphism Interacts with Alcohol and Folate Intake to Influence the Risk of Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Logan, E. Leifer, C. Bredeson, M. Horowitz, M. Ewell, S. Carter, and N. Geller Use of biological assignment in hematopoietic stem cell transplantation clinical trials Clinical Trials, December 1, 2008; 5(6): 607 - 616. [Abstract] [PDF]
|
|
|
|
 |
|
 M. W. J. Strachan, R. M. Reynolds, B. M. Frier, R. J. Mitchell, and J. F. Price The relationship between type 2 diabetes and dementia Br. Med. Bull., December 1, 2008; 88(1): 131 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Sagoo, I. Tatt, G. Salanti, A. S. Butterworth, N. Sarwar, M. van Maarle, J. W. Jukema, B. Wiman, J. J. P. Kastelein, A. M. Bennet, et al. Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis Am. J. Epidemiol., December 1, 2008; 168(11): 1233 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R Bentley, P Emrani, and P A Cassano Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review Thorax, November 1, 2008; 63(11): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zacho, A. Tybjaerg-Hansen, J. S. Jensen, P. Grande, H. Sillesen, and B. G. Nordestgaard Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease N. Engl. J. Med., October 30, 2008; 359(18): 1897 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kivimaki, G. D. Smith, N. J. Timpson, D. A. Lawlor, G. D. Batty, M. Kahonen, M. Juonala, T. Ronnemaa, J. S.A. Viikari, T. Lehtimaki, et al. Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study Eur. Heart J., October 2, 2008; 29(20): 2552 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bochud On the use of Mendelian randomization to infer causality in observational epidemiology Eur. Heart J., October 2, 2008; 29(20): 2456 - 2457. [Full Text] [PDF]
|
|
|
|
 |
|
 N. J Timpson, P. M Emmett, T. M Frayling, I. Rogers, A. T Hattersley, M. I McCarthy, and G. Davey Smith The fat mass-and obesity-associated locus and dietary intake in children Am. J. Clinical Nutrition, October 1, 2008; 88(4): 971 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Palmer, J. R Thompson, M. D Tobin, N. A Sheehan, and P. R Burton Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses Int. J. Epidemiol., October 1, 2008; 37(5): 1161 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D Tobin, M. Kahonen, P. Braund, T. Nieminen, C. Hajat, M. Tomaszewski, J. Viik, R. Lehtinen, G A. Ng, P. W Macfarlane, et al. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations Int. J. Epidemiol., October 1, 2008; 37(5): 1132 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Lewis, D. A Lawlor, B. G Nordestgaard, A. Tybjaerg-Hansen, S. Ebrahim, J. Zacho, A. Ness, S. Leary, and G. D. Smith The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts. Eur. J. Endocrinol., July 1, 2008; 159(1): 35 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bjorge, A. Engeland, A. Tverdal, and G. D. Smith Body Mass Index in Adolescence in Relation to Cause-specific Mortality: A Follow-up of 230,000 Norwegian Adolescents Am. J. Epidemiol., July 1, 2008; 168(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. F. Wilson CETP Genes, Metabolic Effects, and Coronary Disease Risk JAMA, June 18, 2008; 299(23): 2795 - 2796. [Full Text] [PDF]
|
|
|
|
|
|
R. Frikke-Schmidt, B. G. Nordestgaard, M. C. A. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease JAMA, June 4, 2008; 299(21): 2524 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. O Shaheen Prenatal nutrition and asthma: hope or hype? Thorax, June 1, 2008; 63(6): 483 - 485. [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dangour, E. Breeze, R. Clarke, P. S. Shetty, R. Uauy, and A. E. Fletcher Plasma Homocysteine, but Not Folate or Vitamin B-12, Predicts Mortality in Older People in the United Kingdom J. Nutr., June 1, 2008; 138(6): 1121 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Smith 'Something funny seems to happen': J.B.S. Haldane and our chaotic, complex but understandable world Int. J. Epidemiol., June 1, 2008; 37(3): 423 - 426. [Full Text] [PDF]
|
|
|
|
|
|
R. Schnabel, M. G. Larson, J. Dupuis, K. L. Lunetta, I. Lipinska, J. B. Meigs, X. Yin, J. Rong, J. A. Vita, C. Newton-Cheh, et al. Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection Hypertension, June 1, 2008; 51(6): 1651 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Folsom, J. S. Pankow, J. M. Peacock, S. J. Bielinski, G. Heiss, and E. Boerwinkle Variation in TCF7L2 and Increased Risk of Colon Cancer: The Atherosclerosis Risk in Communities (ARIC) Study Diabetes Care, May 1, 2008; 31(5): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Freathy, N. J. Timpson, D. A. Lawlor, A. Pouta, Y. Ben-Shlomo, A. Ruokonen, S. Ebrahim, B. Shields, E. Zeggini, M. N. Weedon, et al. Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI Diabetes, May 1, 2008; 57(5): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bochud, A. Chiolero, R. C Elston, and F. Paccaud A cautionary note on the use of Mendelian randomization to infer causation in observational epidemiology Int. J. Epidemiol., April 1, 2008; 37(2): 414 - 416. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Smith and S. Ebrahim Reply Int. J. Epidemiol., April 1, 2008; 37(2): 416 - 417. [Full Text] [PDF]
|
|
|
|
|
|
S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al. Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Nilsson Is adiponectin and its genetic regulators useful or not for prediction of carotid intima-media thickness and coronary heart disease? Eur. Heart J., February 1, 2008; 29(3): 293 - 295. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger Proximal, Distal, and the Politics of Causation: What's Level Got to Do With It? Am J Public Health, February 1, 2008; 98(2): 221 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Frayling Commentary: Genetic association studies see light at the end of the tunnel Int. J. Epidemiol., February 1, 2008; 37(1): 133 - 135. [Full Text] [PDF]
|
|
|
|
|
|
M. Johansson, J. D. McKay, F. Wiklund, S. Rinaldi, M. Verheus, C. H. van Gils, G. Hallmans, K. Balter, H.-O. Adami, H. Gronberg, et al. Implications for Prostate Cancer of Insulin-Like Growth Factor-I (IGF-I) Genetic Variation and Circulating IGF-I Levels J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4820 - 4826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. D. Smith, and D.A. Lawlor Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women's Heart and Health Study and Meta-Analysis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2729 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Baker, T. Rahman, D. Hall, P. J Avery, B. M Mayosi, J. M C Connell, M. Farrall, H. Watkins, and B. Keavney The C-532T polymorphism of the angiotensinogen gene is associated with pulse pressure: A possible explanation for heterogeneity in genetic association studies of AGT and hypertension Int. J. Epidemiol., December 1, 2007; 36(6): 1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qi, N. Rifai, and F. B. Hu Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women Diabetes, December 1, 2007; 56(12): 3075 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Crawley and G. Davey Smith Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter? Arch. Dis. Child., December 1, 2007; 92(12): 1058 - 1061. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Vollset, J. Igland, M. Jenab, A. Fredriksen, K. Meyer, S. Eussen, H. K. Gjessing, P. M. Ueland, G. Pera, N. Sala, et al. The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2416 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Macleod Cannabis use and psychosis: the origins and implications of an association Adv. Psychiatr. Treat., November 1, 2007; 13(6): 400 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies Collaboration Am. J. Epidemiol., October 15, 2007; 166(8): 867 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. T. Higgins, J. Little, J. P. A. Ioannidis, M. S. Bray, T. A. Manolio, L. Smeeth, J. A. Sterne, B. Anagnostelis, A. S. Butterworth, J. Danesh, et al. Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association Am. J. Epidemiol., October 15, 2007; 166(8): 863 - 866. [Full Text] [PDF]
|
|
|
|
|
|
M. Kivimaki, D. A. Lawlor, G. D. Smith, C. Eklund, M. Hurme, T. Lehtimaki, J. S. A. Viikari, and O. T. Raitakari Variants in the CRP Gene as a Measure of Lifelong Differences in Average C-Reactive Protein Levels: The Cardiovascular Risk in Young Finns Study, 1980 2001 Am. J. Epidemiol., October 1, 2007; 166(7): 760 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanderson, G. Salanti, and J. Higgins Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) Genes and Smoking on Bladder Carcinogenesis: A Literature-based Systematic HuGE Review and Evidence Synthesis Am. J. Epidemiol., October 1, 2007; 166(7): 741 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fewell, G. D. Smith, and J. A. C. Sterne Fewell et al. Respond to "Fuel for Debate" Am. J. Epidemiol., September 15, 2007; 166(6): 659 - 661. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, S. C. Johnston, E. Ziv, D. Kado, J. A. Cauley, and K. Yaffe Methylenetetrahydrofolate Reductase C677T Polymorphism and Cognitive Function in Older Women Am. J. Epidemiol., September 15, 2007; 166(6): 672 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, M. J Shrubsole, R. M Ness, D. Schlundt, Q. Cai, W. E Smalley, M. Li, Y. Shyr, and W. Zheng The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk Am. J. Clinical Nutrition, September 1, 2007; 86(3): 743 - 751. [Abstract] [Full Text] [PDF]
|
|